Current through September 24, 2024
1.
Possession of Survey Instrument(s). A registrant authorized to use a
therapeutic radiation machine in accordance with 1.15.7 shall possess
appropriately calibrated portable monitoring equipment. As a minimum, such
equipment shall include a portable radiation measurement survey instrument
capable of measuring dose rates over the range 1 mrem (10 µSv) per hour
to 1000 mrem (10 mSv) per hour. The survey instrument(s) shall be operable and
calibrated in accordance with 1.15.8.
2
Leakage Radiation Outside the Maximum
Useful Beam in Photon and Electron Modes.
a. The absorbed dose rate due to leakage
radiation (excluding neutrons) at any point outside the maximum sized useful
beam, but within a circular plane of radius 2 meters which is perpendicular to
and centered on the central axis of the useful beam at the nominal treatment
distance (i.e., patient plane), shall not exceed a maximum of 0.2 percent and
an average of 0.1 percent of the absorbed dose rate on the central axis of the
beam at the nominal treatment distance. Measurements shall be averaged over an
area up to but not exceeding 100 square centimeters at the positions
specified;
b. Except for the area
defined in 1.15.7(2)(a), the absorbed dose rate in tissue (excluding that from
neutrons) at I meter from the electron path between the source and the target
or electron window shall not exceed 0.5 percent of the absorbed dose rate in
tissue on the central axis of the beam at the nominal treatment distance.
Measurements shall be averaged over an area up to but not exceeding 100 square
centimeters at the positions specified;
c. The neutron absorbed dose rate outside the
useful beam shall be kept as low as practicable. Measurements of the portion of
the leakage radiation dose contributed by neutrons shall be averaged over an
area up to but not exceeding 800 square centimeters; and d. For each
therapeutic radiation machine, the registrant shall determine, or obtain from
the manufacturer, the leakage radiation existing at the positions specified in
1.15.7(2)(a) through 1.15.7(2)(c) for the specified operating conditions.
Records on leakage radiation measurements shall be maintained at the
installation for inspection by the Agency.
3
Leakage Radiation Through
Beam-Limiting Devices.
a. Photon
Radiation. All adjustable or interchangeable beam-limiting devices shall
attenuate the useful beam such that:
i. At the
nominal treatment distance, the maximum absorbed dose anywhere in the area
shielded by the beam-limiting device(s) shall not exceed 2 percent of the
maximum absorbed dose on the central axis of the useful beam measured in a 10
centimeters by 10 centimeters radiation field.
ii. For fields of any size in which the
maximum area shielded by the beam-limiting devices exceeds 500 square
centimeters, the product of the average absorbed dose due to leakage radiation
through the beam-limiting devices and the maximum area protectable by the
beam-limiting devices shall not exceed one tenth (0.1) of the product of the
maximum absorbed dose on the central axis of the useful beam and the area of
the useful beam for a radiation field of 10 centimeters by 10 centimeters. All
values of absorbed dose and area are referred to the nominal treatment
distance.
b. Electron
Radiation. All adjustable or interchangeable electron applicators shall
attenuate the radiation, including but not limited to photon radiation
generated by electrons incident on the beam-limiting device and electron
applicator and other parts of the radiation head, such that the following
limits apply:
i. The absorbed dose in a plane
perpendicular to the central axis of the useful beam at the nominal treatment
distance shall not exceed:
i. An average of 2
percent of the absorbed dose on the central axis of the useful beam at the
nominal treatment distance. This limit shall apply in the area between a line 4
centimeters outside the periphery of the geometrical radiation field and the
border of the maximum area protectable by the electron applicator;
and
ii. A maximum of 10 percent of
the absorbed dose on the central axis of the useful beam at the nominal
treatment distance. This limit shall apply in the area between a line 2
centimeters outside the periphery of the geometrical radiation field and the
border of the maximum area protectable by the electron
applicator.
ii. For
fields of any size in which the maximum area shielded by the electron
applicator exceeds 1000 square centimeters, the product of the average absorbed
dose due to leakage radiation through the electron applicators and the maximum
area protectable by the electron applicators shall not exceed two tenths (0.2)
of the product of the maximum absorbed dose on the central axis of the useful
beam and the area of the useful beam for a radiation field of 10 centimeters by
10 centimeters. All values of absorbed dose and area are referred to the
nominal treatment distance.
c. Measurement of Leakage Radiation.
i. Photon Radiation. Measurements of leakage
radiation through the beam-limiting devices shall be made with the
beam-limiting devices closed and any residual aperture blocked by at least two
(2) tenth value layers of suitable absorbing material. In the case of
overlapping beam-limiting devices, the leakage radiation through each set shall
be measured independently, and the leakage radiation from each set shall not
exceed a maximum of 2 percent anywhere in the area protectable by that
beam-limiting device.
ii. Electron
Radiation. Measurements of leakage radiation through the electron applicators
shall be made with the electron beam directed into the air and using a
radiation detector of area up to but not exceeding 1 square centimeter suitably
protected against radiation which has been scattered from material beyond the
radiation detector. Measurements shall be made using 1 centimeter of tissue
equivalent build up material.
d. When adjustable beam-limiting devices are
used, the position and shape of the radiation field shall be indicated by a
light field.
4
Filters/Wedges.
a. Each filter
and/or wedge which is removable from the system shall be clearly marked with an
identification number. For removable wedge filters, the nominal wedge angle
shall appear on the wedge or wedge tray (if permanently mounted to the tray).
If the wedge or wedge tray is damaged, the wedge transmission factor shall be
redetermined;
b. If the absorbed
dose rate information required by 1.15.7(9) relates exclusively to operation
with a field flattening or beam scattering filter in place, such filter shall
be removable only by the use of tools;
c. For equipment manufactured after the
effective date of these regulations which utilize a system of wedge filters,
interchangeable field flattening filters, or interchangeable beam scattering
foils:
i. Irradiation shall not be possible
until a selection of a filter or a positive selection to use "no filter" has
been made at the treatment control panel, either manually or
automatically;
ii. An interlock
system shall be provided to prevent irradiation if the filter selected is not
in the correct position;
iii. A
display shall be provided at the treatment control panel showing the wedge
filter(s), interchangeable field flattening filter(s), and/or interchangeable
beam scattering foil(s) in use; and
iv. An interlock shall be provided to prevent
irradiation if any filter and/or beam scattering foil selection operation
carried out in the treatment room does not agree with the filter and/or beam
scattering foil selection operation carried out at the treatment control panel.
5
X-Ray
Stray Radiation in the Useful Electron Beam. For equipment manufactured
after the effective date of these regulations, the registrant shall determine
during acceptance testing, or obtain from the manufacturer, data sufficient to
ensure that x-ray stray radiation in the useful electron beam, absorbed dose at
the surface during x-ray irradiation and stray neutron radiation in the useful
x-ray beam are in compliance with International Electrotechnical Commission
(IEC) Document 601-2-1 (most current revision).
6. Beam Monitors. All therapeutic radiation
machines subject to 1.15.7 shall be provided with beam monitoring devices. The
sensors for this device shall be fixed in the useful beam during treatment, (or
interlocked) to indicate the air kerma rate or dose rate.
a. Equipment manufactured after the effective
date of these regulations shall be provided with at least two independently
powered integrating dose meters. Alternatively, a common power supply may be
used if the production of radiation is terminated upon failure of any common
element.
b. Equipment manufactured
on or before the effective date of these regulations shall be provided with at
least one radiation detector. This detector shall be incorporated into a
primary beam monitoring system;
c.
The detector and the system into which that detector is incorporated shall meet
the following requirements:
i. Each detector
shall be removable only with tools and, if movable, shall be interlocked to
prevent incorrect positioning;
ii.
Each detector shall form part of a beam monitoring system from whose readings
in dose monitor units the absorbed dose at a reference point in the treatment
volume can be calculated;
iii. Each
beam monitoring system shall be capable of independently monitoring,
interrupting, and terminating irradiation; and
iv. For equipment manufactured after the
effective date of these regulations, the design of the beam monitoring systems
shall ensure that the:
i. Malfunctioning of
one system shall not affect the correct functioning of the secondary system;
and
ii. Failure of any element
common to both systems which could affect the correct function of both systems
shall terminate irradiation or prevent the initiation of radiation.
v. Each beam monitoring system
shall have a legible display at the treatment control panel. For equipment
manufactured after the effective date of these regulations, each display shall:
i. maintain a reading until intentionally
reset;
ii. have only one scale and
no electrical or mechanical sc ale multiplying factors;
iii. utilize a design such that increasing
dose is displayed by increasing numbers; and
iv. In the event of power failure, the beam
monitoring information required in 1.15.7(6)(c)(v)(iii) displayed at the
control panel at the time of failure shall be retrievable in at least one
system for a 20 minute period of time.
7
Beam Symmetry.
a. Bent-beam linear accelerators subject to
1.15.7 shall be provided with auxiliary device(s) to monitor beam
symmetry;
b. The device(s)
referenced in 1.15.7(7)(a) shall be able to detect field asymmetry greater than
10 percent; and c. The device(s) referenced in 1.15.7(7)(a) shall be configured
to terminate irradiation if the specifications in 1.15.7(7)(b) cannot be
maintained.
8
Selection and Display of Dose Monitor Units.
a. Irradiation shall not be possible until a
selection of a number of dose monitor units has been made at the treatment
control panel;
b. The preselected
number of dose monitor units shall be displayed at the treatment control panel
until reset manually for the next irradiation;
c. After termination of irradiation, it shall
be necessary to reset the dosimeter display before subsequent treatment can be
initiated; and
d. For equipment
manufactured after the effective date of these regulations, after termination
of irradiation, it shall be necessary for the operator to reset the preselected
dose monitor units before irradiation can be initiated.
9. Air Kerma Rate/Absorbed Dose Rate. For
equipment manufactured after the effective date of these regulations, a system
shall be provided whose readings the air kerma rate or absorbed dose rate at a
reference point in the treatment volume can be calculated. [The radiation
detectors specified in 1.15.7(6) may form part of this system.] In addition:
a. The dose monitor unit dose rate shall be
displayed at the treatment control panel;
b. If the equipment can deliver under any
conditions, an air kerma rate or absorbed dose rate at the nominal treatment
distance more than twice the maximum value specified by the manufacturer, a
device shall be provided which terminates irradiation when the air kerma rate
or absorbed dose rate exceeds a value twice the specified maximum. The dose
rate at which the irradiation will be terminated shall be a record maintained
by the registrant; and
c. For
equipment manufactured after the effective date of these regulations, if the
equipment can deliver under any conditions an air kerma rate or absorbed dose
rate at the nominal treatment distance more than ten (10) times the maximum
value specified by the manufacturer, a device shall be provided to prevent the
air kerma rate or absorbed dose rate anywhere in the radiation field from
exceeding twice the specified maximum value and to terminate irradiation if the
excess absorbed dose at the nominal treatment distance exceeds 400 rad (4 Gy).
10
Termination of
Irradiation by the Beam Monitoring System or Systems During Stationary Beam
Radiation Therapy.
a. Each primary
system shall terminate irradiation when the preselected number of dose monitor
units has been detected by the system;
b. If original design of the equipment
included a secondary dose monitoring system, that system shall be capable of
terminating irradiation when not more than 15 percent or 40 dose monitor units
above the preselected number of dose monitor units set at the control panel has
been detected by the secondary dose monitoring system; and
c. For equipment manufactured after the
effective date of these regulations, an indicator on the control panel shall
show which monitoring system has terminated irradiation.
11. Termination Switches. It shall be
possible to terminate irradiation and equipment movement or go from an
interruption condition to termination condition at any time from the operator's
position at the treatment control panel.
12. Interruption Switches. If a therapeutic
radiation machine has an interrupt mode, it shall be possible to interrupt
irradiation and equipment movements at any time from the treatment control
panel. Following an interruption, it shall be possible to restart irradiation
by operator action without any reselection of operating conditions. If any
change is made of a preselected value during an interruption, irradiation and
equipment movements shall be automatically terminated.
13. Timer. A suitable irradiation control
device shall be provided to terminate the irradiation after a preset time
interval.
a. A timer shall be provided which
has a display at the treatment control panel. The timer shall have a preset
time selector and an elapsed time indicator;
b. The timer shall be a cumulative timer
which activates with an indication of "BEAM-ON" and retains its reading after
irradiation is interrupted or terminated. After irradiation is terminated and
before irradiation can be reinitiated, it shall be necessary to reset the
elapsed time indicator;
c. For
equipment manufactured after the effective date of these regulations, after
termination of irradiation and before irradiation can be reinitiated, it shall
be necessary for the operator to reset the preset time selector; and d. The
timer shall terminate irradiation when a preselected time has elapsed, if the
dose monitoring systems have not previously terminated irradiation.
14. Selection of Radiation Type.
Equipment capable of both x-ray therapy and electron therapy shall meet the
following additional requirements: a. Irradiation shall not be possible until a
selection of radiation type (x-rays or electrons) has been made at the
treatment control panel;
b. The radiation
type selected shall be displayed at the treatment control panel before and
during irradiation;
c. An interlock
system shall be provided to ensure that the equipment can principally emit only
the radiation type which has been selected;
d. An interlock system shall be provided to
prevent irradiation with x-rays except to obtain a verification film, when
electron applicators are fitted;
e.
An interlock system shall be provided to prevent irradiation with electrons
when accessories specific for x-ray therapy are fitted; and
f An interlock system shall be provided to prevent
irradiation if any selected operations carried out in the treatment room do not
agree with the selected operations carried out at the treatment control
panel.
15.
Selection of Energy. Equipment capable of generating radiation beams of
different energies shall meet the following requirements:
a. Irradiation shall not be possible until a
selection of energy has been made at the treatment control panel;
b. The measured energy value selected shall
be displayed (MV for photons and MeV for electrons) at the treatment control
panel before and during irradiation; and
c. Irradiation shall not be possible until
the appropriate flattening filter or scattering foil for the selected energy is
in its proper location.
16
Selection of Stationary Beam
Radiation Therapy or Rotational Arc Radiation Therapy. Therapeutic
radiation machines capable of both stationary beam radiation therapy and
rotational arc radiation therapy shall meet the following requirement:
a. Irradiation shall not be possible until a
selection of stationary beam radiation therapy or rotational arc radiation
therapy has been made at the treatment control panel;
b. The mode of operation shall be displayed
at the treatment control panel;
c.
An interlock system shall be provided to ensure that the equipment can operate
only in the mode which has been selected;
d. An interlock system shall be provided to
prevent irradiation if any selected parameter in the treatment room does not
agree with the selected parameter at the treatment control panel;
e. Rotational arc radiation therapy shall be
controlled to obtain the selected relationships between incremental dose
monitor units and incremental angle of movement:
i. For equipment manufactured after the
effective date of these regulations, an interlock system shall be provided to
terminate irradiation if the number of dose monitor units delivered in any 15
degrees of arc differs by more than 20 percent from the selected
value;
ii. For equipment
manufactured after the effective date of these regulations, where gantry angle
terminates the irradiation in rotational arc radiation therapy, the dose
monitor units shall differ by less than 5 percent from the value calculated
from the absorbed dose per unit angle and total angle relationship;
iii. For equipment manufactured after the
effective date of these regulations, an interlock shall be provided to prevent
the gantry moving more than 5 degrees beyond the selected angular limits during
rotational arc radiation therapy; and
iv. For equipment manufactured after the
effective date of these regulations, an interlock shall be provided to require
that a selection of direction be made at the treatment control panel in all
units which are capable of both clockwise and counter-clockwise rotational arc
radiation therapy.
f.
Where the beam monitor system terminates the irradiation in rotational arc
radiation therapy, the termination of irradiation shall be as required by
1.15.7(10); and
g. For equipment
manufactured after the effective date of these regulations, an interlock system
shall be provided to terminate irradiation if movement of the gantry:
i. occurs during stationary beam radiation
therapy; or
ii. stops during
rotational arc radiation therapy unless such stoppage is a preplanned function.
17
Facility Design Requirements for Therapeutic Radiation Machines Operating
above 500 kV. In addition to shielding adequate to meet requirements of
1.15.9, the following design requirements are made:
a. Protective Barriers. All protective
barriers shall be fixed, except for access doors to the treatment room or
movable beam interceptors;
b.
Control Panel. In addition to other requirements specified in Subchapter 15,
the control panel shall also:
i. Be located
outside the treatment room;
ii.
Provide an indication of whether electrical power is available at the control
panel and if activation of the radiation is possible;
iii. Provide an indication of whether
radiation is being produced; and
iv. Include an access control (locking)
device which will prevent unauthorized use of the therapeutic radiation
machine;
c. Viewing
Systems. Windows, mirrors, closed-circuit television or an equivalent viewing
system shall be provided to permit continuous observation of the patient
following positioning and during irradiation and shall be so located that the
operator may observe the patient from the treatment control panel. The
therapeutic radiation machine shall not be used for patient irradiation unless
at least one viewing system is operational;
d. Aural Communications. Provision shall be
made for continuous two-way aural communication between the patient and the
operator at the control panel. The therapeutic radiation machine shall not be
used for irradiation of patients unless continuous two-way aural communication
is possible;
e. Room Entrances.
Treatment room entrances shall be provided with warning lights in a readily
observable position near the outside of all access doors, which will indicate
when the useful beam is "ON" and when it is "OFF";
f. Entrance Interlocks. Interlocks shall be
provided such that all entra nce doors must be closed before treatment can be
initiated or continued. If the radiation beam is interrupted by any door
opening, it shall not be possible to restore the machine to operation without
closing the door and reinitiating irradiation by manual action at the control
panel;
g. Beam Interceptor
Interlocks. If the shielding material in any protective barrier requires the
presence of a beam interceptor to ensure compliance with 1.4.14(1), and
1.4.14(2) of these regulations, interlocks shall be provided to prevent the
production of radiation, unless the beam interceptor is in place, whenever the
useful beam is directed at the designated barrier(s);
h. Emergency Cutoff Switches. At least one
(1) "scram button" or other emergency power cutoff switch shall be located in
the radiation therapy room and shall terminate all equipment electrical power
including radiation and mechanical motion. This switch is in addition to the
termination switch required by 1.15.7(11). All emergency power cutoff switches
shall include a manual reset so that the therapeutic radiation machine cannot
be restarted from the unit's control console without resetting the emergency
cutoff switch;
i. Safety
Interlocks. All safety interlocks shall be designed so that any defect or
component failure in the safety interlock system prevents or terminates
operation of the therapeutic radiation machine; and
j. Surveys for Residual Radiation. Surveys
for residual activity, shall be conducted on all therapeutic radiation machines
capable of generating photon and electron energies above 10 MV prior to
machining, removing, or working on therapeutic radiation machine components
which may have become activated due to photo-neutron production.
18
Radiation
Therapy Physicist Support.
a. The
services of a Radiation Therapy Physicist shall be utilized in facilities
having therapeutic radiation machines with energies of 500 kV and above. The
Radiation Therapy Physicist shall be responsible for:
i. Full calibration(s) required by 1.15.7(20)
and protection surveys required by 1.15.4(1);
ii. Supervision and review of
dosimetry;
iii. Beam data
acquisition and storage for computerized dosimetry, and supervision of its
use;
iv. Quality assurance,
including quality assurance check review required by 1.15.7(21)(e) of these
regulations;
v. Consultation with
the authorized user in treatment planning , as needed; and
vi. Perform calculations/assessments
regarding misadministrations.
b. If the Radiation Therapy Physicist is not
a full-time employee of the registrant, the operating procedures required by
1.15.7(19) shall also specifically address how the Radiation Therapy Physicist
is to be contacted for problems or emergencies, as well as the specific
actions, if any, to be taken until the Radiation Therapy Physicist can be
contacted.
19
Operating Procedures.
a. No
individual other than the patient shall be in the treatment room during
treatment of a patient or during any irradiation for testing or calibration
purposes;
b. Therapeutic radiation
machines shall not be made available for medical use unless the requirements of
1.15.4(1), 1.15.7(20), and 1.15.7(21) have been met;
c. Therapeutic radiation machines, when not
in operation, shall be secured to prevent unauthorized use;
d. If a patient must be held in position
during treatment, mechanical supporting or restraining devices shall be used;
and
e. A copy of the current
operating and emergency procedures shall be maintained at the therapeutic
radiation machine control console.
20
Full Calibration
Measurements.
a. Full calibration of a
therapeutic radiation machine subject to 1.15.7 shall be performed by, or under
the direct supervision of, a Radiation Therapy Physicist:
i. Before the first medical use following
installation or reinstallation of the therapeutic radiation machine;
ii. At intervals not exceeding 1 year;
and
iii. Before medical use under
the following conditions:
i. Whenever quality
assurance check measurements indicate that the radiation output differs by more
than 5 percent from the value obtained at the last full calibration and the
difference cannot be easily discerned; and
ii. Following any component replacement,
major repair, or modification of components that could significantly affect the
characteristics of the radiation beam.
iv. Notwithstanding the requirements of
1.15.7(20)(a)(iii):
i. Full calibration of
therapeutic radiation machines with multi-energy and/or multi-mode capabilities
is required only for those modes and/or energies that are not within their
acceptable range; and
ii. If the
repair, replacement or modification does not affect all modes and/or energies,
full calibration shall be performed on the affected mode/energy that is in most
frequent clinical use at the facility. The remaining energies/modes may be
validated with quality assurance check procedures against the criteria in
1.15.7(20)(a)(iii)(i).
b. To satisfy the requirement of
1.15.7(1)(a), full calibration shall include all measurements required for
annual calibration by American Association of Physicists in Medicine (AAPM)
Report 13, "Physical Aspects of Quality Assurance in Radiation
Therapy";
c. The registrant shall
use the dosimetry system described in 1.15.4(3) to measure the radiation output
for one set of exposure conditions. The remaining radiation measurements
required in 1.15.7(20)(b) may then be made using a dosimetry system that
indicates relative dose rates; and
d. The registrant shall maintain a record of
each calibration for the duration of the registration. The record shall include
the date of the calibration, the manufacturer's name, model number, and serial
number for the therapeutic radiation machine, the model numbers and serial
numbers of the instruments used to calibrate the therapeutic radiation machine,
and the signature of the Radiation Therapy Physicist responsible for performing
the calibration.
21
Periodic Quality Assurance Checks.
a. Periodic quality assurance checks shall be
performed on all therapeutic radiation machines subject to 1.15.7 at intervals
not to exceed 1 week;
b. To satisfy
the requirement of 1.15.7(21)(a), quality assurance checks shall include
determination of all parameters for periodic quality assurance checks contained
in American Association of Physicists in Medicine (AAPM) Report 13, "Physical
Aspects of Quality Assurance in Radiation Therapy";
c. The registrant shall use a dosimetry
system which has been intercompa red within the previous 6 months with the
dosimetry system described in 1.15.4(3) to make the periodic quality assurance
checks required in 1.15.7(21)(b);
d. The registrant shall perform periodic
quality assurance checks required by 1.15.7(21)(a) in accordance with
procedures established by the Radiation Therapy Physicist;
e. The registrant shall review the results of
each periodic radiation output check according to the following procedures:
i. The authorized user and Radiation Therapy
Physicist shall be immediately notified if any parameter is not within its
acceptable range. The therapeutic radiation machine shall not be made available
for subsequent medical use until the Radiation Therapy Physicist has determined
that all parameters are within their acceptable range;
ii. If all quality assurance check parameters
appear to be within their acceptable range, the quality assurance check shall
be reviewed and signed by either the authorized user or Radiation Therapy
Physicist within 3 treatment days; and
iii. The Radiation Therapy Physicist shall
review and sign the results of each radiation output quality assurance check at
intervals not to exceed 1 month;
f. Therapeutic radiation machines subject to
1.15.7 shall have safety quality assurance checks of each radiation therapy
facility performed at intervals not to exceed 1 week;
g. To satisfy the requirement of
1.15.7(21)(f), safety quality assurance checks shall ensure proper operation
of:
i. Electrical interlocks at each external
beam radiation therapy room entrance;
ii. Proper operation of the "BEAM-ON",
interrupt and termination switches;
iii. Beam condition indicator lights on the
access doors, control console, and in the radiation therapy room;
iv. Viewing systems;
v. Electrically operated treatment room
door(s) from inside and outside the treatment room; and
vi. At least one emergency power cutoff
switch. If more than one emergency power cutoff switch is installed and not all
switches are tested at once, each switch shall be tested on a rotating basis.
Safety quality assurance checks of the emergency power cutoff switches may be
conducted at the end of the treatment day in order to minimize possible
stability problems with the therapeutic radiation machine.
h. The registrant shall promptly repair any
system identified in 1.15.7(21)(g) that is not operating properly;
and
i. A registrant shall maintain
a record of each quality assurance check required by 1.15.7(21)(a) and
1.15.7(21)(g) for 3 years. The record shall include the date of the quality
assurance check, the manufacturer's name, model number, and serial number for
the therapeutic radiation machine, the manufacturer's name, model number and
serial number of the instrument(s) used to measure the radiation output of the
therapeutic radiation machine, and the signature of the individual who
performed the periodic quality assurance check.
Miss. Code Ann.
§
45-14-11